Enanta Pharmaceuticals, Inc. (ENTA)

13.21 -0.30 (-2.22%) USD  |  NASDAQ  |  Feb 23, 11:50
More

Enanta Pharmaceuticals Other Receivables (Quarterly)

Other Receivables (Quarterly) Chart

View Other Receivables (Quarterly) for ENTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Receivables (Quarterly) Range, Past 5 Years

View Other Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Receivables (Quarterly) Benchmarks

View Other Receivables (Quarterly) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --
BioMarin Pharmaceutical, Inc. Upgrade